(0.32%) 5 116.31 points
(0.30%) 38 354 points
(0.36%) 15 986 points
(-0.99%) $83.02
(5.36%) $2.03
(0.27%) $2 353.60
(0.40%) $27.65
(4.12%) $960.05
(-0.27%) $0.932
(-0.46%) $10.97
(-0.57%) $0.796
(1.66%) $93.40
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 8.94%
@ $49.09
発行日: 14 2月 2024 @ 23:30
リターン: 15.79%
前回のシグナル: 2月 10 - 05:40
前回のシグナル:
リターン: -2.06 %
Live Chart Being Loaded With Signals
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support...
Stats | |
---|---|
本日の出来高 | 188 463 |
平均出来高 | 671 158 |
時価総額 | 3.07B |
EPS | $0 ( 2024-02-21 ) |
次の収益日 | ( $0.450 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 177.63 |
ATR14 | $0.0380 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-30 | Bolton Stephanie | Buy | 7 744 | Ordinary Shares |
2024-03-30 | Bolton Stephanie | Buy | 10 746 | Stock Appreciation Rights |
2024-03-30 | Bolton Stephanie | Sell | 3 643 | Ordinary Shares |
2024-03-30 | Bolton Stephanie | Buy | 4 915 | Restricted Stock Units |
2024-03-30 | Bolton Stephanie | Buy | 4 915 | Performance Stock Units |
INSIDER POWER |
---|
50.90 |
Last 100 transactions |
Buy: 371 593 | Sell: 126 373 |
ボリューム 相関
LivaNova PLC 相関
10 最も負の相関 | |
---|---|
SERA | -0.945 |
NEO | -0.938 |
XLRN | -0.93 |
TA | -0.93 |
MLTX | -0.922 |
NTRA | -0.92 |
ZGNX | -0.91 |
XPON | -0.909 |
CPTA | -0.908 |
PAE | -0.908 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
LivaNova PLC 相関 - 通貨/商品
LivaNova PLC 財務諸表
Annual | 2023 |
収益: | $1.15B |
総利益: | $785.45M (68.09 %) |
EPS: | $0.330 |
FY | 2023 |
収益: | $1.15B |
総利益: | $785.45M (68.09 %) |
EPS: | $0.330 |
FY | 2022 |
収益: | $1.02B |
総利益: | $707.20M (69.21 %) |
EPS: | $-1.610 |
FY | 2021 |
収益: | $1.04B |
総利益: | $705.99M (68.19 %) |
EPS: | $-2.68 |
Financial Reports:
No articles found.
LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。